Differential effects of neurofibromin gene dosage on melanocyte development

Journal of Investigative Dermatology

Volumn 133, Issue 1, 2013, Pages 49-58

  Deo, Mugdha ^a   Huang, Jenny Li Ying ^a   Fuchs, Helmut ^b   De Angelis, Martin Hrabe ^b   Van Raamsdonk, Catherine D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MATURATION; DERMIS; EMBRYO; EPIDERMIS; FEMALE; GENE DOSAGE; GENE LOSS; GENE MAPPING; HAPLOINSUFFICIENCY; HETEROZYGOTE; HYPERPIGMENTATION; MELANOCYTE; MISSENSE MUTATION; MOLECULAR CLONING; MOUSE; NONHUMAN; PIGMENT CELL; PRIORITY JOURNAL; SCHWANN CELL; SKIN COLOR;

EID: 84872183990     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.240     Document Type: Article

References (48)

1. Adameyko I, Lallemend F, Aquino JB et al. (2009) Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell 139:366-799
2. Adameyko I, Lallemend F, Furlan A et al. (2012) Sox2 and Mitf crossregulatory interactions consolidate progenitor and melanocyte lineages in the cranial neural crest. Development 139:397-4100
3. Alizadeh A, Fitch KR, Niswender CM et al. (2008) Melanocyte-lineage expression of Cre recombinase using Mitf regulatory elements. Pigment Cell Melanoma Res 21:63-99
4. Bhowmick NA, Chytil A, Plieth D et al. (2004) TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303:848-511
5. Boyd KP, Korf BR, Theos A (2009) Neurofibromatosis type 1. J Am Acad Dermatol 61:1-14; quiz 15-166
6. Brems H, Chmara M, Sahbatou M et al. (2007) Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype. Nat Genet 39:1120-66
7. Cichowski K, Jacks T (2001) NF1 tumor suppressor gene function: Narrowing the GAP. Cell 104:593-6044
8. Crowe F, Schull W, Neel J (1956) A Clinical, Pathological and Genetic Study of Multiple Neurofibromatosis. Springfield, ILL
9. de Boer J, Williams A, Skavdis G et al. (2003) Transgenic mice with hematopoietic and lymphoid specific expression of Cre. Eur J Immunol 33:314-255
10. De Schepper S, Boucneau J, Lambert J et al. (2005) Pigment cell-related manifestations in neurofibromatosis type 1: An overview. Pigment Cell Res 18:13-244
11. De Schepper S, Boucneau J, Vander Haeghen Y et al. (2006) Cafe-au-lait spots in neurofibromatosis type 1 and in healthy control individuals: Hyperpigmentation of a different kind? Arch Dermatol Res 297:439-499
12. De Schepper S, Maertens O, Callens T et al. (2008) Somatic mutation analysis in NF1 cafe au lait spots reveals two NF1 hits in the melanocytes. J Invest Dermatol 128:1050-33
13. Doerflinger NH, Macklin WB, Popko B (2003) Inducible site-specific recombination in myelinating cells. Genesis 35:63-722
14. Evans DG, Baser ME, McGaughran J et al. (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311-44
15. Fetsch JF, Michal M, Miettinen M (2000) Pigmented (melanotic) neurofibroma: A clinicopathologic and immunohistochemical analysis of 19 lesions from 17 patients. Am J Surg Pathol 24:331-433
16. Fitch KR, McGowan KA, van Raamsdonk CD et al. (2003) Genetics of dark skin in mice. Genes Dev 17:214-288
17. Fountain JW, Wallace MR, Bruce MA et al. (1989) Physical mapping of a translocation breakpoint in neurofibromatosis. Science 244:1085-77
18. Hirobe T (1984) Histochemical survey of the distribution of the epidermal melanoblasts and melanocytes in the mouse during fetal and postnatal periods. Anat Rec 208:589-944
19. Hrabe de Angelis M, Flaswinkel H, Fuchs H et al. (2000) Genome-wide, large-scale production of mutant mice by ENU mutagenesis. Nat Genet 25:444-77
20. Jacks T, Shih TS, Schmitt EM et al. (1994) Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nat Genet 7:353-611
21. Jiao Z, Zhang ZG, Hornyak TJ et al. (2006) Dopachrome tautomerase (Dct) regulates neural progenitor cell proliferation. Dev Biol 296:396-4088
22. Jordan SA, Jackson IJ (2000) MGF (KIT ligand) is a chemokinetic factor for melanoblast migration into hair follicles. Dev Biol 225:424-366
23. Kunisada T, Yoshida H, Ogawa M et al. (1996) Characterization and isolation of melanocyte progenitors from mouse embryos. Develop Growth Differentiation 38:87-977
24. Le LQ, Shipman T, Burns DK et al. (2009) Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas. Cell Stem Cell 4:453-633
25. Lewandoski M, Meyers EN, Martin GR (1997) Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harb Symp Quant Biol 62:159-688
26. Mackenzie MA, Jordan SA, Budd PS et al. (1997) Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev Biol 192:99-1077
27. Maertens O, Brems H, Vandesompele J et al. (2006) Comprehensive NF11 screening on cultured Schwann cells from neurofibromas. Hum Mutat 27:1030-400
28. Maertens O, De Schepper S, Vandesompele J et al. (2007) Molecular dissection of isolated disease features in mosaic neurofibromatosis type 1. Am J Hum Genet 81:243-511
29. Mayer TC (1973) The migratory pathway of neural crest cells into the skin of mouse embryos. Dev Biol 34:39-466
30. Mayes DA, Rizvi TA, Cancelas JA et al. (2011) Perinatal or adult Nf11 inactivation using tamoxifen-inducible PlpCre each cause neurofibroma formation. Cancer Res 71:4675-855
31. Morcos P, Thapar N, Tusneem N et al. (1996) Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles. Mol Cell Biol 16:2496-5033
32. Peters EM, Tobin DJ, Botchkareva N et al. (2002) Migration of melanoblasts into the developing murine hair follicle is accompanied by transient c-Kit expression. J Histochem Cytochem 50:751-666
33. Powell MB, Hyman P, Bell OD et al. (1995) Hyperpigmentation and melanocytic hyperplasia in transgenic mice expressing the human T244 Ha-ras gene regulated by a mouse tyrosinase promoter. Mol Carcinog 12:82-900
34. Scheffzek K, Ahmadian MR, Wiesmuller L et al. (1998) Structural analysis of the GAP-related domain from neurofibromin and its implications. EMBO J 17:4313-277
35. Schweizer J, Marks F (1977) A developmental study of the distribution and frequency of Langerhans cells in relation to formation of patterning in mouse tail epidermis. J Invest Dermatol 69:198-2044
36. Shishido E, Kadono S, Manaka I et al. (2001) The mechanism of epidermal hyperpigmentation in dermatofibroma is associated with stem cell factor and hepatocyte growth factor expression. J Invest Dermatol 117:627-333
37. Shrestha P, Muramatsu Y, Kudeken W et al. (1998) Localization of Ca(2+)- binding S100 proteins in epithelial tumours of the skin. Virchows Arch 432:53-99
38. Soriano P (1999) Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat Genet 21:70-11
39. Srinivas S, Watanabe T, Lin CS et al. (2001) Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev Biol 1:44
40. Van Raamsdonk CD, Fitch KR, Fuchs H et al. (2004) Effects of G-protein mutations on skin color. Nat Genet 36:961-88
41. Wallace MR, Marchuk DA, Andersen LB et al. (1990) Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF11 patients. Science 249:181-66
42. Widlund HR, Fisher DE (2003) Microphthalamia-associated transcription factor: A critical regulator of pigment cell development and survival. Oncogene 22:3035-411
43. Wu J, Williams JP, Rizvi TA et al. (2008) Plexiform and dermal neurofibromas and pigmentation are caused by Nf1 loss in desert hedgehog-expressing cells. Cancer Cell 13:105-166
44. Yang FC, Chen S, Clegg T et al. (2006) Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling. Hum Mol Genet 15:2421-377
45. Yang FC, Ingram DA, Chen S et al. (2008) Nf1-dependent tumors require a microenvironment containing Nf1+/- and c-kit-dependent bone marrow. Cell 135:437-488
46. Yoshida H, Kunisada T, Kusakabe M et al. (1996) Distinct stages of melanocyte differentiation revealed by anlaysis of nonuniform pigmentation patterns. Development 122:1207-144
47. Zabierowski SE, Fukunaga-Kalabis M, Li L et al. (2011) Dermis-derived stem cells: A source of epidermal melanocytes and melanoma? Pigment Cell Melanoma Res 24:422-99
48. Zhu Y, Romero MI, Ghosh P et al. (2001) Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain. Genes Dev 15:859-766